Ideas
Fab construction drives equipment demand.
Regardless of uncertainty about memory capex, actual semiconductor fabs are being built, guaranteeing sustained equipment demand. Reduce Samsung Electronics and SK Hynix weight from 50% to 40% and increase semiconductor equipment allocation from 10% to 20%. If individual equipment stocks are hard to pick, use a sector ETF.
Overreaction; strong earnings ahead.
The sell-off in Alteogen was driven by overdone rumors about Samsung Epis competition and a false report about a major shareholder selling. The company's SC platform is unique, and upcoming Q2 earnings will show meaningful revenue for the first time, validating the platform. Historically speaking, this is the time to buy.
Avoid if TargeFAT-tide deal false.
If Peptron is not genuinely executing the TargeFAT-tide obesity drug deal, the stock lacks valuation support. The CEO buying shares with 1.1 billion won is likely a result of his own missteps, and any bounce should be used to sell.
Substrate stocks set to rebound.
Substrate and MLCC stocks like Samsung Electro-Mechanics have corrected enough and are showing signs of a turnaround. Barclays published a positive note on semiconductors including MLCC. A technical rebound to around 1.6 million won seems possible. For those stuck at higher prices, patience is advised.
LTA turns SK Hynix range-bound.
The memory cycle is showing clear signs of peaking. Year-over-year price growth rates are decelerating, similar to the pattern just before the 2021 downturn called by Morgan Stanley. Even with record earnings, the slowdown in growth will be used as a reason to correct. He has turned net short and advises selling any bounce near prior highs.
KOSDAQ ready for strong rebound.
KOSDAQ has suffered extreme selling, forced margin liquidations have cleared supply, and the market structure is now thin on sellers. Relative strength versus KOSPI has been improving for weeks. This sets up a strong rebound. He is holding KOSDAQ ETFs.
Oversold biotech for long-term rebound.
For investors with a longer time horizon who find active trading difficult, deeply sold-off pharma/biotech large-caps offer higher expected returns than chasing semiconductors here. His own portfolio has 30% in biotech, favoring names with real earnings like Samsung Biologics and Celltrion.
KOSPI oversold, poised to bounce.
KOSPI large-caps have also been heavily sold off during the panic, creating attractive levels. He has recently increased his KOSPI weight from 60% to 65%, suggesting oversold large-caps are poised to bounce alongside the broader market recovery.
Oversold on ETF flows; cheap.
Hyundai Motor has fallen significantly not because of fundamental changes but due to capital being rotated into leveraged Samsung/SK Hynix ETFs. The robot business story and other fundamentals remain intact, possible positive catalysts in August, and the stock is cheap. He is personally buying small amounts.
This 3PRO TV (삼프로TV) video, published July 15, 2026,
features Lee Kwon-hee, Park Byeong-chang, Lee Jae-kyu
discussing KORU, 196170.KQ, 087010.KQ, 009150.KS, 005930.KS, 000660.KS, KOSDAQ, 068270.KS, 207940.KS, EWY, 005380.KS.
9 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Lee Kwon-hee,
Park Byeong-chang,
Lee Jae-kyu
· Tickers:
KORU,
196170.KQ,
087010.KQ,
009150.KS,
005930.KS,
000660.KS,
KOSDAQ,
068270.KS,
207940.KS,
EWY,
005380.KS